{ event: "article_read", name: `Monitoring Individuals with IAb Positive Status`, author: ``, tags: `Monitoring | Staging | Infographic`, publication_date: ``, interaction_type: "content" } 
- Resource
- BR1DGE
- Monitoring
- Staging
- Infographic
Monitoring Individuals with IAb Positive Status
Explore how clinical outcomes are impacted by screening and monitoring
Learning Objectives
- Understand the benefits of early identification and monitoring of individuals with positive islet autoantibody status
Summary
Individuals with positive islet autoantibody (IAb) status can be identified early via IAb screening. Individuals who test positive for IAbs include those who are at risk of developing presymptomatic T1D (Stages 1 and 2) (1 IAb) or have presymptomatic T1D (Stage 1 or 2) (≥2 IAbs).
Early identification and subsequent monitoring of individuals with positive IAb status can provide time to prepare for the future. Screening and monitoring can lead to beneficial clinical outcomes at onset of Stage 3 T1D and beyond.
.svg)
MAT-GLB-2405124-1.0 - 12/2024
Similar Content
